,i #aagth ,,congress #ast ,session ,h4 ,r4 #bdje ,,in ,,the ,,house ,,of ,,representatives ,april #h1 #bjba,mr4 ,griffith 7for himself and ,mr4 ,crenshaw7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend the ,controlled ,substances ,act to improve the process for conducting scientific research on schedule ,i controlled substances1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,streamlining ,research on ,controlled ,substances ,act of #bjba4 #b4 ,clarification of certain registration requirements related to research 7a7 ,exception for agents or employees of registered researchers ,section #cjb7;c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbb7;c77 is amended in paragraph 7#a7 by striking or dispenser and inserting dispenser1 or researcher4 7b7 ,conforming amendment ,section #ajb7c7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7c77 is amended by striking or dispenser and inserting dispenser1 or researcher4 7c7 ,single registration for contiguous research sites ,section #cjb7;e7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbb7;e77 is amended by adding at the end the following new paragraph3 7#c7 ,notwithstanding paragraph 7#a71 a person registered to conduct research with a controlled substance under section #cjc7;f7 may conduct such research under a single registration if such research occurs exclusively on a single1 contiguous campus and the registrant notifies the ,attorney ,general in writing of all sites on the campus where the research will be conducted or where the controlled substance will be stored or administered4 ,the registrant must so notify the ,attorney ,general prior to conducting research at such additional sites4 4 7d7 ,new inspection not required in certain situations ,section #cjc7;f7 of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7;f77 is amended-- 7#a7 by redesignating paragraphs 7#a7 through 7#e7 as subparagraphs 7,a7 through 7,e71 respectively1 and by moving the margins of such subparagraphs two ems to the right2 7#b7 by striking 7f7 ,the and inserting 7f77#a7 ,the2 and 7#c7 by adding at the end1 after the matter following subparagraph 7,e71 as so redesignated1 the following new paragraph3 7#b7 7,a7 ,if a person is registered to conduct research with a controlled substance and applies for a registration1 or a modification of a registration to conduct research with a second controlled substance that is in the same schedule or in a schedule with a higher numerical designation1 a new inspection by the ,attorney ,general of the registered location is not required4 7,b7 ,nothing in this paragraph shall prohibit the ,attorney ,general from conducting any inspection if the ,attorney ,general deems it necessary4 4 7e7 ,continuation of research on substances newly added to schedule ,i2 authority ,to conduct research with other substances in schedule ,i ,section #cjb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbb7 is amended by adding at the end the following new subsection3 7h7 ,continuation of research on substances newly added to schedule ,i2 authority ,to conduct research with other substances in schedule ,i 7#a7 ,if a person is conducting research on a substance at the time the substance is added to schedule ,i1 and such person is already registered to conduct research with a controlled substance in schedule ,i or ,,ii then-- 7,a7 the person shall1 within #cj days of the scheduling of the newly scheduled substance1 submit a completed application for registration or modification of existing registration1 to conduct research on such substance1 in accordance with the regulations issued by the ,attorney ,general2 7,b7 the person may1 notwithstanding subsections 7a7 and 7b71 continue to conduct the research on such substance until the application referred to in subparagraph 7,a7 is withdrawn by the applicant or until the ,attorney ,general serves on the applicant an order to show cause proposing the denial of the application pursuant to section #cjd7;c72 and 7,c7 if the ,attorney ,general serves such an order to show cause and the applicant requests a hearing1 such hearing shall be held on an expedited basis and not later than #de days after the request is made1 except that the hearing may be held at a later time if so requested by the applicant4 7#b7 7,a7 ,a person who is registered to conduct research with a controlled substance in schedule ,i may1 notwithstanding subsections 7a7 and 7b71 conduct research with another controlled substance in schedule ,i1 provided the following conditions are met3 7i7 ,the person has applied for a modification of the person's registration to authorize research with such other controlled substance in accordance with the regulations issued by the ,attorney ,general4 7ii7 ,the ,attorney ,general has obtained verification from the ,secretary that the research protocol submitted with the application is meritorious4 7iii7 ,the ,attorney ,general has determined that such activity is consistent with ,united ,states obligations under the ,single ,convention on ,narcotic ,drugs1 #aifa4 ,the ,attorney ,general shall make such determination not later than #cj days after receiving the application referred to in clause 7i74 7,b7 ,nothing in this section shall be construed to alter the authority of the ,attorney ,general to initiate proceedings to deny1 suspend1 or revoke any registration in accordance with sections #cjc and #cjd4 4 7f7 ,treatment of certain activities as coincident to research ,section #cjb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbb71 as amended by subsection 7d71 is further amended by adding at the end the following new subsection3 7i7 ,treatment of certain activities as coincident to research 7#a7 ,in general ,except as specified in paragraph 7#b71 a person who is registered to perform research with a controlled substance may perform the following activities with small quantities of that substance1 as set forth in the relevant statement or protocol filed with the application for registration approved by the ,attorney ,general without being required to obtain a manufacturing registration3 7,a7 ,processing the substance to create extracts1 tinctures1 oils1 solutions1 derivatives1 or other forms of the substance consistent with the approved research protocol4 7,b7 ,dosage form development for the purpose of satisfying regulatory requirements implemented by the ,food and ,drug ,administration for submitting an investigational new drug application4 7#b7 ,exception regarding marihuana ,the authority under paragraph 7#a7 does not include authority to grow marihuana4 4 #c4 ,review of research registration process 7a7 ,review ,not later than one year after the date of the enactment of this section1 the ,attorney ,general and the ,secretary of ,health and ,human ,services shall conduct a review of the processes used to obtain or modify ,federal authorization to conduct research with controlled substances1 including-- 7#a7 an evaluation of the impacts of the amendments made by section #b on the risk of the diversion of controlled substances used in research and related public safety considerations2 and 7#b7 identification of opportunities to reduce any unnecessary burden on persons seeking registration1 potential redundancies1 and inefficiencies in the process to obtain or modify ,federal authorization to conduct research with controlled substances1 including the process for obtaining a registration under section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 and the process by which the ,secretary of ,health and ,human ,services reviews research protocols4 7b7 ,guidance ,following the review described in subsection 7a71 the ,attorney ,general and the ,secretary of ,health and ,human ,services shall1 as appropriate1 jointly issue guidance to registrants and potential registrants clarifying the process for registration under section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc74